Diagnostic Laboratories

Langford, United Kingdom

Diagnostic Laboratories

Langford, United Kingdom
SEARCH FILTERS
Time filter
Source Type

Receive press releases from iHealthcareAnalyst, Inc.: By Email Multiplexed Molecular Diagnostics Market by Technologies, Applications, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Multiplexed Molecular Diagnostics Market by Technology (Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next Generation Sequencing Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostic, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) Maryland Heights, MO, April 27, 2017 --( Browse Multiplexed Molecular Diagnostics Market by Technology (Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next Generation Sequencing Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostic, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/ The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high density multiplexed assays, next generation sequencing assays), application (allergies, autoimmune diseases, cardiac diseases, infectious disease diagnostic, oncology, pregnancy & fertility testing), end users (academic research institutes, clinical research organizations, diagnostic laboratories, hospital, pharmaceutical companies). The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. Major players operating in the global multiplexed molecular diagnostics market and profiled in this report include Abbott Laboratories, Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Luminex Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc. 1. Technology 1.1. Low Density Multiplexed Assays (plex ≤ 5) 1.2. Medium Density Multiplexed Assays (plex < 500) 1.3. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) 1.4. Very High Density Multiplexed Assays (> 10,000-plex) 1.5. Next Generation Sequencing Assays 2. Application 2.1. Allergies 2.2. Autoimmune Diseases 2.3. Cardiac Diseases 2.4. Infectious Disease Diagnostic 2.5. Oncology 2.6. Pregnancy & Fertility Testing 3. End Users 3.1. Academic Research Institutes 3.2. Clinical Research Organizations 3.3. Diagnostic Laboratories 3.4. Hospital 3.5. Pharmaceutical Companies 4. Geography (Region, Country) 4.1. North America (U.S., Canada) 4.2. Latin America (Brazil, Mexico, Rest of LA) 4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 4.4. Asia Pacific (Japan, China, India, Rest of APAC) 4.5. Rest of the World 5. Company Profiles 5.1. Abbott Laboratories 5.2. Agilent Technologies 5.3. bioMérieux SA 5.4. Bio-Rad Laboratories, Inc. 5.5. F. Hoffmann-La Roche Ltd. 5.6. Hologic, Inc. 5.7. Illumina, Inc. 5.8. Luminex Corporation 5.9. Siemens Healthineers 5.10. Thermo Fisher Scientific, Inc. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, April 27, 2017 --( PR.com )-- The development and implementation of highly multiplex molecular diagnostic tests have allowed clinical microbiology laboratories to more rapidly and sensitively detect a variety of pathogens directly in clinical specimens. The industry with new molecular diagnostic (MDx) tests is significantly less costly, while simultaneously increasing the number of targets per test through high multiplexing. The advanced technology has the potential to drive growth in the market, particularly in areas such as infectious disease testing, genetic analysis, and personalized medicine. Validation of a large number of disease markers in both molecular and protein diagnostics has paved the way for the emergence of the multiplex assay. The simple low-throughput multiplex assays followed by low-level multiplexing and high-throughput array-based immunoassays are replaced with two types of high-level multiplexing and high-throughput diagnostic methods using microspot arrays and bead arrays. Benefits of using multiplex molecular diagnostics array platforms include improved-quality patient care, as well as cost effectiveness and time saving.Browse Multiplexed Molecular Diagnostics Market by Technology (Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next Generation Sequencing Assays), Application (Allergies, Autoimmune Diseases, Cardiac Diseases, Infectious Disease Diagnostic, Oncology, Pregnancy & Fertility Testing), End Users (Academic Research Institutes, Clinical Research Organizations, Diagnostic Laboratories, Hospital, Pharmaceutical Companies) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/The global multiplexed molecular diagnostics market segmentation is based on technology (low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high density multiplexed assays, next generation sequencing assays), application (allergies, autoimmune diseases, cardiac diseases, infectious disease diagnostic, oncology, pregnancy & fertility testing), end users (academic research institutes, clinical research organizations, diagnostic laboratories, hospital, pharmaceutical companies).The global multiplexed molecular diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global multiplexed diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global multiplexed molecular diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.Major players operating in the global multiplexed molecular diagnostics market and profiled in this report include Abbott Laboratories, Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Luminex Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc.1. Technology1.1. Low Density Multiplexed Assays (plex ≤ 5)1.2. Medium Density Multiplexed Assays (plex 10,000-plex)1.5. Next Generation Sequencing Assays2. Application2.1. Allergies2.2. Autoimmune Diseases2.3. Cardiac Diseases2.4. Infectious Disease Diagnostic2.5. Oncology2.6. Pregnancy & Fertility Testing3. End Users3.1. Academic Research Institutes3.2. Clinical Research Organizations3.3. Diagnostic Laboratories3.4. Hospital3.5. Pharmaceutical Companies4. Geography (Region, Country)4.1. North America (U.S., Canada)4.2. Latin America (Brazil, Mexico, Rest of LA)4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)4.4. Asia Pacific (Japan, China, India, Rest of APAC)4.5. Rest of the World5. Company Profiles5.1. Abbott Laboratories5.2. Agilent Technologies5.3. bioMérieux SA5.4. Bio-Rad Laboratories, Inc.5.5. F. Hoffmann-La Roche Ltd.5.6. Hologic, Inc.5.7. Illumina, Inc.5.8. Luminex Corporation5.9. Siemens Healthineers5.10. Thermo Fisher Scientific, Inc.To request Table of Contents and Sample Pages of this report visit:https://www.ihealthcareanalyst.com/report/multiplex-molecular-diagnostics-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


The global immunohistochemistry (IHC) market is estimated to reach a value of USD 3.1 billion by 2025 The rising prevalence of cancer and increasing healthcare expenses driven by expanding aging population base are recognized to be the most influential factors driving the growth of the immunohistochemistry market. Furthermore, the rapid growth of biotech industry highlighted by increase in growth and revenue coupled with increase in stock market capitalization will nurture the growth. Cancer has high morbidity and mortality risk associated with them. The diagnosis of the disease is majorly dependent on the stage of the disease at admission. This has led to the high demand of immunohistochemistry products. IHC staining process is performed on cancer tissues to reveal the presence of HER2 receptors and/or hormone receptors on their surface. This information plays a vital role in planning the treatment for the disease, creating a demand for immunohistochemistry products. In addition, the rising popularity of targeted immunotherapy and biologic therapy for anticancer drug development and the increasing approvals of the same by the FDA to treat specific types of cancer are expected to benefit the growth in the long run. Other important factors driving growth include the alarming rise in healthcare spending and the shift in focus on value-based healthcare solutions. In 2015, the U.S. healthcare spending witnessed an increase of 5.8% to reach a value of USD 3.2 trillion. To curb the issue and establish a more value-based healthcare delivery, hospitals and care facilities are adopting a more specific and targeted therapy for better outcomes. Key Topics Covered: 1. Methodology and Scope 2. Executive Summary 3. Immunohistochemistry Market Variables, Trends & Scope 3.1. Market Segmentation & Scope 3.2. Immunohistochemistry: Market Dynamics 3.2.1. Market driver analysis 3.2.2. Market restraint analysis 3.3. Key Opportunities Prioritized 3.3.1. Key opportunities prioritized, by product 3.3.2. Key opportunities prioritized, by application 3.3.3. Key opportunities prioritized, by end-use 3.4. Immunohistochemistry - SWOT Analysis, By Factor (Political & legal, economic and technological) 4. Immunohistochemistry: Product Estimates & Trend Analysis 4.1. Immunohistochemistry Market: Product Movement Analysis 4.2. Antibodies 4.2.2. Primary Antibodies 4.2.3. Secondary Antibodies 4.3. Reagents 4.3.2. Histological Stains 4.3.3. Blocking Sera and Reagents 4.3.4. Chromogenic Substrates  4.3.5. Fixation Reagents 4.3.6. Stabilizers 4.3.7. Organic Solvents 4.3.8. Proteolytic Enzymes 4.3.9. Diluents 4.4. Equipment 4.4.2. Slide Staining Systems 4.4.3. Tissue Microarrays 4.4.4. Tissue Processing Systems 4.4.5. Slide Scanners 4.4.6. Others 4.5. Kits 5. Immunohistochemistry: Application Estimates & Trend Analysis 5.1. Immunohistochemistry Market: Application Movement Analysis 5.2. Diagnostics 5.2.2. Cancer 5.2.3. Infectious Diseases 5.2.4. Cardiovascular diseases 5.2.5. Autoimmune Diseases 5.2.6. Diabetes Mellitus 5.2.7. Nephrological Diseases 5.3. Drug Testing  6. Immunohistochemistry: End-Use Estimates & Trend Analysis 6.1. Immunohistochemistry Market: Application Movement Analysis 6.2. Hospitals and Diagnostic Laboratories 6.3. Research Institutes 6.4. Others 7. Immunohistochemistry: Regional Estimates & Trend Analysis, by Product, Application, and End-use 8. Competitive Landscape For more information about this report visit http://www.researchandmarkets.com/research/gkgmnp/immunohistochemist Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/31-billion-immunohistochemistry-ihc-market-analysis-and-forecast-segments-2014-2025-by-product-application--end-uses---research-and-markets-300455123.html


DUBLIN, May. 10, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Kidney Function Tests Market Analysis By Product (Dilution & Concentration, Clearance, Urine, Imaging Tests), By End-use (Hospitals, Diagnostic Laboratories, Academic Research...


Global E. Coli Testing Market: Scope of the Report The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the E. coli testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. Global E. Coli Testing Market: Key Segments Based on testing methods, the E. coli testing market has been majorly segmented into: environmental testing method and clinical testing method. In terms of environmental testing methods divided into membrane filtration (MF), multiple tube fermentation (MTF), and enzyme substrate methods. In terms of clinical testing methods divided into polymerase chain reaction (PCR) tests, enzyme immunoassays (EIA) and others. Based on end-users, the market has been broadly classified into environmental testing end-user and clinical testing end-user. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of E. coli related disease incidences and adoption of E. coli tests for water testing worldwide, technological advancement, and growing number of use of water testing E. coli test in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year. Global E. Coli Testing Market: Regional Outlook Geographically, the market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter's five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global E. coli testing market. Companies Mentioned in the Report The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global E. coli testing market. The report also profiles key players operating in the market which are IDEXX Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., CPI International, Inc., Bio-Rad Laboratories, Inc., Pro-Lab Diagnostics, Inc., Alere Inc., BioMerieux Inc., NanoLogix, Inc. and other prominent companies. The global E. coli testing market is segmented as follows: Global E. Coli Testing Market, by Testing Methods Environmental Testing Method Membrane Filtration (MF) Multiple Tube Fermentation (MTF) Enzyme Substrate Methods Clinical Testing Method Polymerase Chain Reaction (PCR) Tests Enzyme Immunoassays (EIA) Others Global E. Coli Testing Market, by End-user Environmental Testing Method Home and Drinking Water Suppliers Bottled Water Suppliers Waste Water Treatment Organizations Others (Government Agencies, Private Well Owners, Ground Water Testing and Farm Water Testing) Clinical Testing Method Hospital Diagnostic Laboratories Physician Offices Global E. Coli Testing Market, by Geography North America U.S. Canada Europe Germany U.K. France Italy Spain Rest of the Europe Asia Pacific China Japan Australia & New Zealand Rest of Asia Latin America (LATAM) Brazil Mexico Rest of LATAM Middle East & Africa GCC Countries South Africa Download the full report: https://www.reportbuyer.com/product/4885793/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/e-coli-testing-market---global-industry-analysis-size-share-growth-trends--forecast-2017---2025-300453784.html


Global Mycoplasma Diagnostics Market: Scope of the Report The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global mycoplasma diagnostic market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/techniques /end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. Global Mycoplasma Diagnostics Market: Key Segments The global mycoplasma diagnostics market has been studied based on major product segments, technique segment, their end-users, and regional as well as national markets. Based on product type, the global market has been categorized into three major 4 segments: Kits & reagents, instruments, software's & services. On the basis of technology the mycoplasma diagnostics market are classified as PCR (Polymerase Chain Reaction), Immunoassay (ELISA, RIA), DNA staining, Microbial Culture Techniques, Others. On the basis of end users the market has been classified as hospitals, diagnostic laboratories, clinics and others. The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year. Global Mycoplasma Diagnostics Market: Regional Outlook Geographically, the mycoplasma diagnostic market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for microfluidics has been further categorized into major product, technology, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year. Companies Mentioned in the Report The report also profiles key players operating in the microfluidics market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others. The global mycoplasma diagnostics market is segmented as follows: Mycoplasma Diagnostics Market, by Product Kits & Reagents Instruments Software & Services Mycoplasma Diagnostics Market, by Technology PCR Immunoassay ELISA RIA DNA staining Microbial Culture Techniques Others Mycoplasma Diagnostics Market, by End Users Hospitals Diagnostic Laboratories Clinics Others Global Multiplexed Diagnostics Market, by Region North America U.S. Canada Europe Germany U.K. France Italy Spain Rest of Europe Asia Pacific India China Japan Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa Saudi Arabia South Africa Download the full report: https://www.reportbuyer.com/product/4885785/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mycoplasma-diagnostics-market-dna-staining-and-microbial-culture-techniques-end-users---hospitals-diagnostic-laboratories-and-clinics---global-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300453774.html


Global Pressure Monitoring Devices Market Forecast to 2024 – New Report by Data Bridge Market Research Global Pressure Monitoring Devices Market, By Product Type (Blood pressure, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors, Intracranial Pressure Monitors and Other Pressure Monitoring Devices), By Application (Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders, Dialysis), By Procedure (Non-invasive and Invasive), By End User, By Distribution Channel, By Geography – Industry Trends and Forecast to 2024 Dallas, TX, February 22, 2017 --( The global pressure monitoring devices market is segmented on the basis of product type, application, procedure, end-user, distribution channel and geography. On the basis of the product type the market is segmented into blood pressure (Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers, BP Transducers), Pulmonary Pressure Monitors (Oximeters, Capnographs, Spirometers), Intraocular Pressure Monitors (Prisms, Prisms Sterilizers, Tip Covers, Sensors). Based on application the market is segmented into Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders and Dialysis. On the basis of Procedure the market is segmented into Invasive and Non-invasive. Based on end-user the market is segmented into Hospitals, Ambulatory Surgical Centres and Clinics, Diagnostic Laboratories, and Physician. Request for sample pages: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. The report includes company share data for different geographies including Global, North America, Europe and APAC. Read more: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/ The key players operating in this market are Withings SA, Koninklijke Philips N.V., American Diagnostic Corporation, General Electric Company, Welch Allyn, OMRON HEALTHCARE Co. Ltd., A&D Medical, SunTech Medical, Inc., Spirit Medical Co., Briggs Healthcare, Drägerwerk AG & Co. KGaA, Siemens Healthcare GmbH, Medtronic, CAS Medical Systems, Inc., Rossmax International Ltd., GF HEALTH PRODUCTS, INC., OSI Systems, Inc., NIHON KOHDEN CORPORATION., Compumedics Limited, Electrical Geodesics, Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 22, 2017 --( PR.com )-- The Global Pressure Monitoring Devices Market is expected to reach USD 10.7 billion by 2024 from USD 6.5 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The global pressure monitoring devices market is segmented on the basis of product type, application, procedure, end-user, distribution channel and geography.On the basis of the product type the market is segmented into blood pressure (Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers, BP Transducers), Pulmonary Pressure Monitors (Oximeters, Capnographs, Spirometers), Intraocular Pressure Monitors (Prisms, Prisms Sterilizers, Tip Covers, Sensors).Based on application the market is segmented into Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders and Dialysis.On the basis of Procedure the market is segmented into Invasive and Non-invasive.Based on end-user the market is segmented into Hospitals, Ambulatory Surgical Centres and Clinics, Diagnostic Laboratories, and Physician.Request for sample pages: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. The report includes company share data for different geographies including Global, North America, Europe and APAC.Read more: https://databridgemarketresearch.com/reports/global-pressure-monitoring-devices-market/The key players operating in this market are Withings SA, Koninklijke Philips N.V., American Diagnostic Corporation, General Electric Company, Welch Allyn, OMRON HEALTHCARE Co. Ltd., A&D Medical, SunTech Medical, Inc., Spirit Medical Co., Briggs Healthcare, Drägerwerk AG & Co. KGaA, Siemens Healthcare GmbH, Medtronic, CAS Medical Systems, Inc., Rossmax International Ltd., GF HEALTH PRODUCTS, INC., OSI Systems, Inc., NIHON KOHDEN CORPORATION., Compumedics Limited, Electrical Geodesics, Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


Research and Markets has announced the addition of the "Global Endoscopy Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Endoscopy Market is poised to grow at a CAGR of around 6.9% over the next decade to reach approximately $47.6 billion by 2025. This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report is a valuable asset for the existing players, new entrants and the future investors. Some of the prominent trends that the market is witnessing include increasing miniaturization in scope system design, shift to HD (High Definition) and 3D systems, micro endoscope is breakthrough in endoscopy market and new and innovative multiband photonic and spectroscopic imaging methods for endoscopes. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 3.1 Current Trends 3.1.1 Increasing miniaturization in scope system design 3.1.2 Shift to HD (High Definition) and 3D systems 3.1.3 Micro endoscope is breakthrough in endoscopy market 3.1.4 New and innovative multiband photonic and spectroscopic imaging methods for endoscopes 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Endoscopy Market, By Product 4.1 Capsule Endoscopes 4.2 Flexible Endoscopes 4.3 Rigid Endoscopes 4.4 Robot Assisted Endoscopes 4.5 Endoscopic Accessories 4.5.1.1 Cleaning Brushes 4.5.1.2 Fluid Flushing Devices 4.5.1.3 Biopsy Valves 4.5.1.4 Mouthpieces 4.5.1.5 Needle Forceps & Needle Holders 4.5.1.6 Light Cables 4.5.1.7 Surgical Dissectors 4.5.1.8 Other Accessories (Distal Attachments) 4.6 Endoscopic Visualization System 4.6.1.1 Endoscopic Light Sources 4.6.1.2 Endoscopic Cameras 4.6.1.2.1.1 Single-Chip Cameras 4.6.1.2.1.2 3-Chip Cameras 4.6.1.2.1.3 3D Cameras 4.6.1.2.1.4 HD Cameras 4.6.1.3 Camera Heads 4.6.1.4 Video Converters 4.6.1.5 Video Recorders 4.6.1.6 Video Processors 4.6.1.7 Carts 4.6.1.8 Transmitters & Receivers 4.6.1.9 Wireless Displays and Monitors 4.6.1.10 Other Visualization Devices 4.7 Endoscopy Instruments 4.7.1.1 Electronic Endoscopy Equipment 4.7.1.1.1 Endoscopy Ultrasounds (EUS) 4.7.1.1.2 Endoscopy Fluid Management Systems 4.7.1.1.3 Insufflators 4.7.1.1.4 Other Electronic Endoscopy Equipment 4.7.1.2 Mechanical Endoscopy Equipment 4.7.1.2.1.1 Graspers 4.7.1.2.1.2 Snares 4.7.1.2.1.3 Biopsy Forceps 4.7.1.2.1.4 Endoscopic Implants 4.7.1.2.1.5 Trocars and Cannulae 4.7.1.2.1.6 Other Mechanical Endoscopic Instruments 5 Endoscopy Market, By Application 5.1 Angioscope 5.1.1.1 Arthroscopy 5.1.1.2 Cystoscope 5.1.1.3 Hysteroscope 5.2 Choledochoscope 5.2.1.1 Duodenoscope 5.2.1.2 Enteroscope 5.3 ENT Endoscopy 5.4 Chromoendoscopy 5.5 Gastrointestinal (GI) Endoscopy 5.5.1.1 Colonoscope 5.5.1.2 Sigmoidoscope 5.6 Laparoscopy 5.7 Laryngoscopy 5.7.1.1 Bronchoscope 5.8 Mediastinoscopy 5.9 Resectoscope 5.9.1.1 Fetoscope 5.10 Otoscopy 5.11 Obstetrics/Gynecology Endoscopy 5.12 Urology Endoscopy (Cystoscopy) 5.13 Vascolo Surgery Endoscopy 5.14 Video Capsule Endoscopy 6 Endoscopy Market, By End User 6.1 Ambulatory Surgical Centers/Clinics 6.2 Hospitals 6.3 Diagnostic Laboratories 6.4 Academic Research Laboratories 6.5 Other End Users 6.5.1 Other End Users Market Forecast to 2025 (US$ MN) 7 Endoscopy Market, By Geography 8 Key Player Activities 8.1 Acquisitions & Mergers 8.2 Agreements, Partnerships, Collaborations and Joint Ventures 8.3 Product Launch & Expansions 8.4 Other Activities 10 Leading Companies 10.1 Cook Medical Incorporated 10.2 Boston Scientific Corporation 10.3 CapsoVision Inc 10.4 Chongqing Jinshan Science & Technology Co 10.5 Stryker Corporation 10.6 Fujifilm Holding Corporation 10.7 Given Imaging Ltd 10.8 Karl Storz GmbH & Co.Kg 10.9 Olympus Corporation 10.10 IntroMedic Co. Ltd 10.11 RF System Lab 10.12 Medtronic PLC 10.13 Pentax Medical (Hoya Corporation) 10.14 Richard Wolf GmbH 10.15 Smith & Nephew PLC 10.16 Ethicon, Inc 10.17 Maxer Medizintechnik 10.18 B. Braun Melsungen 10.19 Ventura Business Solutions For more information about this report visit http://www.researchandmarkets.com/research/dvstb8/global_endoscopy Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716


Research and Markets has announced the addition of the "Global Wireless Health Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Wireless Health Market is poised to grow at a CAGR of around 23.8% over the next decade to reach approximately $330.5 billion by 2025. This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. Some of the prominent trends that the market is witnessing include increased interest towards self care, rapid proliferation of smartphones and tablets and availability of economical wireless devices. Based on component, the market is categorized hardware and software. Depending on the application the market is segmented by medical & diagnostic laboratories, telehealth, healthcare amenities, home care, pharmaceuticals, physicians and other applications. By services, market is segregated by tablet PC, handheld device, pager health information, PDA, smartphone and mobile phone. Based on technology the market is categorized into WiMAX (Worldwide Interoperability for Microwave Access), WLAN/Wi-Fi, WWAN (Wireless Wide Area Network), WPAN (Wireless Personal Area Network). WWAN (Wireless Wide Area Network) segment is further sub-segmented into CDMA, 3G and 4G, General Packet Radio Service (GPRS) and Global Positioning System (GPS). WPAN (Wireless Personal Area Network) segment is further sub-segmented into Ultra-wide Band (UWB), ZigBee, RFID, RTLS, and IPS, Bluetooth, Z-wave and Ant+. Depending on the end user the market is segmented by payers, patients/individuals and providers. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3 Market Overview 3.1 Current Trends 3.1.1 Increased interest towards self care 3.1.2 Rapid proliferation of smartphones and tablets 3.1.3 Availability of economical wireless devices 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Wireless Health Market, By Component 4.1 Hardware 4.1.1 Hardware Market Forecast to 2025 (US$ MN) 4.2 Software 4.2.1 Software Market Forecast to 2025 (US$ MN) 5 Wireless Health Market, By Application 5.1 Medical & Diagnostic Laboratories 5.1.1 Medical & Diagnostic Laboratories Market Forecast to 2025 (US$ MN) 5.2 Telehealth 5.2.1 Telehealth Market Forecast to 2025 (US$ MN) 5.3 Healthcare Amenities 5.3.1 Healthcare Amenities Market Forecast to 2025 (US$ MN) 5.4 Home Care 5.4.1 Home Care Market Forecast to 2025 (US$ MN) 5.5 Pharmaceuticals 5.5.1 Pharmaceuticals Market Forecast to 2025 (US$ MN) 5.6 Physicians 5.6.1 Physicians Market Forecast to 2025 (US$ MN) 5.7 Other Applications 5.7.1 Other Applications Market Forecast to 2025 (US$ MN) 6 Wireless Health Market, By Service 6.1 Tablet PC 6.1.1 Tablet PC Market Forecast to 2025 (US$ MN) 6.2 Handheld Device 6.2.1 Handheld Device Market Forecast to 2025 (US$ MN) 6.3 Pager Health Information 6.3.1 Pager Health Information Market Forecast to 2025 (US$ MN) 6.4 PDA 6.4.1 PDA Market Forecast to 2025 (US$ MN) 6.5 Smartphone 6.5.1 Smartphone Market Forecast to 2025 (US$ MN) 6.6 Mobile Phone 6.6.1 Mobile Phone Market Forecast to 2025 (US$ MN) 7 Wireless Health Market, By Technology 7.1 WiMAX (Worldwide Interoperability for Microwave Access) 7.1.1 WiMAX (Worldwide Interoperability for Microwave Access) Market Forecast to 2025 (US$ MN) 7.2 WLAN/Wi-Fi 7.2.1 WLAN/Wi-Fi Market Forecast to 2025 (US$ MN) 7.3 WWAN (Wireless Wide Area Network) 7.3.1 WWAN (Wireless Wide Area Network) Market Forecast to 2025 (US$ MN) 7.3.1.1 CDMA 7.3.1.1.1 CDMA Market Forecast to 2025 (US$ MN) 7.3.1.2 3G and 4G 7.3.1.2.1 3G and 4G Market Forecast to 2025 (US$ MN) 7.3.1.3 General Packet Radio Service (GPRS) 7.3.1.3.1 General Packet Radio Service (GPRS) Market Forecast to 2025 (US$ MN) 7.3.1.4 Global Positioning System (GPS) 7.3.1.4.1 Global Positioning System (GPS) Market Forecast to 2025 (US$ MN) 7.4 WPAN (Wireless Personal Area Network) 7.4.1 WPAN (Wireless Personal Area Network) Market Forecast to 2025 (US$ MN) 7.4.1.1 Ultra-wide Band (UWB) 7.4.1.1.1 Ultra-wide Band (UWB) Market Forecast to 2025 (US$ MN) 7.4.1.2 ZigBee 7.4.1.2.1 ZigBee Market Forecast to 2025 (US$ MN) 7.4.1.3 RFID, RTLS, and IPS 7.4.1.3.1 RFID, RTLS, and IPS Market Forecast to 2025 (US$ MN) 7.4.1.4 Bluetooth 7.4.1.4.1 Bluetooth Market Forecast to 2025 (US$ MN) 7.4.1.5 Z-wave 7.4.1.5.1 Z-wave Market Forecast to 2025 (US$ MN) 7.4.1.6 Ant+ 7.4.1.6.1 Ant+ Market Forecast to 2025 (US$ MN) 8 Wireless Health Market, By End User 8.1 Payers 8.1.1 Payers Market Forecast to 2025 (US$ MN) 8.2 Patients/Individuals 8.2.1 Patients/Individuals Market Forecast to 2025 (US$ MN) 8.3 Providers 8.3.1 Providers Market Forecast to 2025 (US$ MN) - AT&T, Inc. - Philips Healthcare - Aerohive Networks, Inc. - Verizon Communications, Inc. - Nihon Kohden Corporation - Allscripts Healthcare Solutions, Inc. - Mckesson Corporation - Siemens A.G. - GE Healthcare - Polar Electro Inc. - Cerner Corporation - Vocera Communication, Inc. - Alcatel-Lucent - Qualcomm, Inc. - Omron Corporation For more information about this report visit http://www.researchandmarkets.com/research/mz4msg/global_wireless


News Article | February 22, 2017
Site: marketersmedia.com

— Europe, the Middle East and Africa Cell Counting Market including classification, application and industry chain overview; Then we deeply analyzed Europe, the Middle East and Africa growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc. In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Europe, the Middle East and Africa Cell Counting Market. Brief TOC for Cell Counting Market: 1 Introduction 1.1 Definition 1.2 Scope of the Study 1.3 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 2.4 Forecast Model 3 Report Excerpt 4 Forecast Indicators 4.1 Introduction 4.2 Growth Drivers 4.3 Growth Barriers 4.4 Growth Opportunities 4.5 Macroecnomical Indicators 5 Market Analysis 6 Europe, the Middle East And Africa Cell Counting Market, By End Users 6.1 Introduction 6.2 Hospitals and Research Institutions 6.3 Diagnostic Laboratories 6.4 Pharmaceutical & Biotechnology Companies, and Cros 6.5 Others Continue… We are thankful for the support and assistance from Europe, the Middle East and Africa Cell Counting Market chain related technical experts and marketing experts during Research Team survey and interviews. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com/


Research and Markets has announced the addition of the "Global Viral Molecular Diagnostics Market Analysis and Trends - Application, Technology, End User - Forecast to 2025" report to their offering. This industry report analyzes the global markets for Viral Molecular Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. Some of the prominent trends that the market is Acceptance of personalized medicine and companion diagnostics, Growth in Proteomics and Genomics Research, Molecular diagnostic tools with new and complex platforms and Introduction of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Based on Application the market is categorized into Infectious diseases, Genetics, Blood Screening and Microbiology. The Infectious diseases segment is further divided into Hepatitis B virus (HBV), Hepatitis C virus (HCV), Human Immunodeficiency Virus (HIV) and Human Papillomavirus (HPV). Based on Technology the market is categorized into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, in situ Hybridization, DNA Sequencing and Next-Generation Sequencing and Other Technologies. The End User segment market is categorized into Hospitals, Diagnostic Laboratories, Academics Institutions and Other End Users. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3.1.3 Molecular diagnostic tools with new and complex platforms For more information about this report visit

Loading Diagnostic Laboratories collaborators
Loading Diagnostic Laboratories collaborators